Machine Learning in High-Alert Medication Treatment: A Study on the Cardiovascular Drug

Machine Learning in High-Alert Medication Treatment: A Study on the Cardiovascular Drug

The safety of high-alert medication treatment is still a challenge all over the world. Approximately one-half of adverse drug events (ADEs) are related to high-alert medications, which motivates us to improve the predicament faced in clinical practice. The purpose of this study is to use machine-lea...

Full description

Bibliographic Details
Main Authors:	Chun-Tien Tai, Kuen-Liang Sue, Ya-Han Hu
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Applied Sciences
Subjects:	machine learning high-alert medication cardiovascular drug adverse drug events decision tree
Online Access:	https://www.mdpi.com/2076-3417/10/17/5798

Similar Items

In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts
by: Hongbin Yang, et al.
Published: (2018-02-01)

Corrigendum: In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts
by: Hongbin Yang, et al.
Published: (2018-04-01)

Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose
by: Yue Wu, et al.
Published: (2021-07-01)

Assessment of Drug Related Problems in Patients with Cardiovascular Diseases in a Tertiary Care Teaching Hospital
by: Javedh Shareef, et al.
Published: (2015-10-01)

The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial
by: T. Bakker, et al.
Published: (2019-08-01)

Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments
by: Giada Crescioli, et al.
Published: (2021-01-01)

Reliability, ease of use and usefulness of I-MeDeSA for evaluating drug-drug interaction alerts in an Australian context
by: Melissa T Baysari, et al.
Published: (2018-10-01)

New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease: The Impact of Treatment Persistence on Morbimortality: A Longitudinal Study
by: Isabel Aguilar-Palacio, et al.
Published: (2020-10-01)

Using the diffusion of innovations theory to assess socio-technical factors in planning the implementation of an electronic health record alert across multiple primary care clinics
by: Ching-Pin Lin, et al.
Published: (2016-04-01)

Pharmaceutical systematics: Description and preliminary investigation of an alternative method for structuring drug information
by: Mary E. Kiersma, et al.
Published: (2011-01-01)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
by: Joshua D. Brown, et al.
Published: (2019-07-01)

Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy
by: Asai, A., et al.
Published: (2022)

Assessment of non-compliance, adverse drug reactions, and drug interactions in patients with cardiovascular diseases admitted to medical wards at Songkhla Hospital
by: J Kanjanakiritamrong, et al.
Published: (2005-08-01)

Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
by: Vivekanandan Kalaiselvan
Published: (2015-11-01)

Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study
by: Ze Yu, et al.
Published: (2021-04-01)

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
by: Hong Yu, et al.
Published: (2019-05-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Devising of a risk map on the management of high risk alert medication in a high level university hospital
by: Hadriana Fernández-Vega, et al.
Published: (2019-05-01)

HOSPITALIZATIONS DUE TO ADVERSE DRUG EVENTS IN THE ELDERLY – A RETROSPECTIVE REGISTER STUDY
by: Outi Laatikainen, et al.
Published: (2016-10-01)

Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older adults
by: Khedidja Hedna, et al.
Published: (2019-06-01)

The prevalence of adverse drug event-related admissions at a local hospital in Malaysia
by: Mahmathi Karuppannan, et al.
Published: (2013-01-01)

Evidence-based usability design principles for medication alerting systems
by: Romaric Marcilly, et al.
Published: (2018-07-01)

A new structure-activity relationship (SAR) model for predicting drug-induced liver injury, based on statistical and expert-basedstructural alerts.
by: Fabiola Pizzo, et al.
Published: (2016-11-01)

Conditions determining decisions on the announcement, change and revocation of alert levels and CRP alert levels
by: Rafał Wróbel
Published: (2020-06-01)

Medication error in anaesthesia and critical care: A cause for concern
by: Dilip Kothari, et al.
Published: (2010-01-01)

Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01)

Assessment of Physician's Knowledge of Potential Drug-Drug Interactions: An Online Survey in China
by: Jing Yuan, et al.
Published: (2021-03-01)

Reporting of adverse events for marketed drugs: Need for strengthening safety database
by: Aditi Anand Apte
Published: (2016-01-01)

Pharmacists’ Attitudes towards Reporting Adverse Drug Events in the United Kingdom
by: Patel, Rachna
Published: (2009)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
by: Joshua D. Brown
Published: (2020-03-01)

Cardiovascular risk and inhibition of cyclooxygenase: traditional nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors
by: M. Campanini, et al.
Published: (2013-05-01)

Development of a high alert intravenous medication
by: Anun Chaikoolvatana, et al.
Published: (2010-08-01)

Causality, Severity and Preventability Assessment of Adverse Cutaneous Drug Reaction: A Prospective Observational Study in a Tertiary Care Hospital
by: Padmavathi S., et al.
Published: (2013-12-01)

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
by: Ruoqi Liu, et al.
Published: (2019-12-01)

Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)

Drug Safety Crises Management in Pharmacovigilance
by: Gloria Shalviri, et al.
Published: (2018-05-01)

Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
by: Fatemeh Mokhtari, et al.
Published: (2014-01-01)

Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system
by: Jessica S. Ancker, et al.
Published: (2017-04-01)

The problem of neurotoxicity of drugs in the treatment of tuberculosis patients
by: G. N. Mozhokina, et al.
Published: (2020-11-01)

Compulsive gambling possibly associated with antiepileptic medication
by: Susanne Storrier, et al.
Published: (2014-01-01)